Heart

Article	Citations
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people	274
Cardiovascular manifestations and treatment considerations in COVID-19	263
Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis	185
COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?	152
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19	148
Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis	142
Place and causes of acute cardiovascular mortality during the COVID-19 pandemic	138
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis	116
Prevalence, incidence and survival of heart failure: a systematic review	90
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure	89
Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China	89
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK	87
Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management	78
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction	77
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19	76
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis	75
Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities	74
Diagnosis, management and therapeutic strategies for congenital long QT syndrome	70
Atrial fibrillation and the prothrombotic state: revisiting Virchow’s triad in 2020	66
Multimodality imaging assessment of mitral annular disjunction in mitral valve prolapse	61
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank	60
Recent advances in percutaneous coronary intervention	54
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis	54
Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017	54
Arrhythmogenic left ventricular cardiomyopathy	53

Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges	53
Global longitudinal strain: clinical use and prognostic implications in contemporary practice	48
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry	47
Differentiation between athlete’s heart and dilated cardiomyopathy in athletic individuals	47
Adult congenital heart disease and the COVID-19 pandemic	46
Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation	46
Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure	45
Pregnancy in congenital heart disease: risk prediction and counselling	44
Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis	43
Maternal cardiovascular risk after hypertensive disorder of pregnancy	42
Longitudinal associations between loneliness, social isolation and cardiovascular events	41
Cardiotoxicities of novel cancer immunotherapies	40
Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China	40
Systematic review of current natural language processing methods and applications in cardiology	39
Limit of detection of troponin discharge strategy versus usual care: randomised controlled trial	39
Cardiac sarcoidosis: state-of-the-art review	38
Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?	38
Colchicine for acute and chronic coronary syndromes	38
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis	38
Sex differences in the association between childhood maltreatment and cardiovascular disease in the UK Biobank	37
Eisenmenger syndrome: diagnosis, prognosis and clinical management	37
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic	36
Recreational substance use among patients with premature atherosclerotic cardiovascular disease	36
Sacubitril/valsartan in the treatment of systemic right ventricular failure	36
Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic	35
Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction	35
Association of physical activity trajectories with major cardiovascular diseases in elderly people	34
Risks and benefits of percutaneous coronary intervention in spontaneous coronary artery dissection	34
The effect of green Mediterranean diet on cardiometabolic risk; a randomised controlled trial	34
COVID-19 and acute myocardial injury: the heart of the matter or an innocent bystander?	34
Parameters associated with ventricular arrhythmias in mitral valve prolapse with significant regurgitation	33
Contrast-enhanced computed tomography assessment of aortic stenosis	32
Advanced imaging of right ventricular anatomy and function	32
Home monitoring with technology-supported management in chronic heart failure: a randomised trial	31
Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial	31
Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models	30
Non-infective endocarditis	30
Cardiovascular disease in homeless versus housed individuals: a systematic review of observational and interventional studies	30
Safety and efficacy of the European Society of Cardiology 0/1-hour algorithm for diagnosis of myocardial infarction: systematic review and meta-analysis	30
Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease	29
Physical activity and the progression of coronary artery calcification	29
Artificial intelligence for the echocardiographic assessment of valvular heart disease	29
Cardiac myxomas: clinical presentation, diagnosis and management	29
Contrast echocardiography: current status and future directions	28
Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic	28
Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis	28
Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation	28
Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease	28
What is ‘normal’ left ventricular ejection fraction?	28
Lipoprotein(a) is robustly associated with aortic valve calcium	28

Diagnostic accuracy of handheld electrocardiogram devices in detecting atrial fibrillation in adults in community versus hospital settings: a systematic review and meta-analysis	27
Socioeconomic status and cardiovascular health in the COVID-19 pandemic	27
New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope	27
Greater admissions, mortality and cost of heart failure in adults with congenital heart disease	26
Clinical outcome of COVID-19 in patients with adult congenital heart disease	26
Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Found	26
Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure	26
Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification	26
Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice	26
Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation	26
Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy	26
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction	25
MRI and CT coronary angiography in survivors of COVID-19	25
Income level and outcomes in patients with heart failure with universal health coverage	25
Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis	25
Survival and risk of recurrence of takotsubo syndrome	24
Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction	24
Endocarditis risk with bioprosthetic and mechanical valves: systematic review and meta-analysis	23
Right ventricle in heart failure with preserved ejection fraction	23
Transcatheter management of severe aortic stenosis during the COVID-19 pandemic	23
Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level	23
Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors	23
Epicardial adipose tissue in obesity-related cardiac dysfunction	23
Sexism experienced by consultant cardiologists in the United Kingdom	23
Association between right ventricular strain and outcomes in patients with dilated cardiomyopathy	23
Brugada syndrome: update and future perspectives	22
Haemodynamic determinants of improved aerobic capacity after tricuspid valve surgery in Ebstein anomaly	22
Prevalence and incidence rates of atrial fibrillation in Norway 2004–2014	22
Update on management of atrial fibrillation in heart failure: a focus on ablation	22
Computed tomography aortic valve calcium scoring for the assessment of aortic stenosis progression	22
Early clinical and haemodynamic matched comparison of balloon-expandable valves	22
Ramadan fasting: recommendations for patients with cardiovascular disease	21
Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation	21
Determinants and prognostic value of echocardiographic first-phase ejection fraction in aortic stenosis	21
Metabolic phenotyping and cardiovascular disease: an overview of evidence from epidemiological settings	21
Comprehensive review of evaluation and management of cardiac paragangliomas	21
Atrial fibrillation: global burdens and global opportunities	21
Association between right ventricle dysfunction and poor outcome in patients with septic shock	21
Risk of infective endocarditis after surgical and transcatheter aortic valve replacement	20
What is the normal composition of pericardial fluid?	20
Cardiovascular outcomes of pregnancy in Turner syndrome	20
Prediction of adverse cardiac events in pregnant women with valvular rheumatic heart disease	20
Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure	20
The ‘wait for symptoms’ strategy in asymptomatic severe aortic stenosis	20
Socioeconomic disparities in prehospital factors and survival after out-of-hospital cardiac arrest	20
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis	20
Heart failure medication dosage and survival in women and men seen at outpatient clinics	20
Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries	20
Neurocognitive and psychosocial outcomes in adult congenital heart disease: a lifespan approach	20
Sex differences in prevalence, treatment and control of cardiovascular risk factors in England	19
Association of heart failure and its comorbidities with loss of life expectancy	19
Regional variation in cardiovascular magnetic resonance service delivery across the UK	19
Left ventricular non-compaction cardiomyopathy: how many needles in the haystack?	19
National Institute for Health and Care Excellence (NICE) guidance on heart valve disease	19
Utility of 3D printed cardiac models in congenital heart disease: a scoping review	19
Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials	19
Anticoagulant prescribing for atrial fibrillation and risk of incident dementia	19
Aortitis: recent advances, current concepts and future possibilities	19
Contemporary demographics, diagnostics and outcomes in non-bacterial thrombotic endocarditis	19
Machine learning model for predicting out-of-hospital cardiac arrests using meteorological and chronological data	19
Clinical outcomes in spontaneous coronary artery dissection	19
Air pollution and cardiovascular disease: the Paul Wood Lecture, British Cardiovascular Society 2021	19
Getting the best from the Heart Team: guidance for cardiac multidisciplinary meetings	18
Quality of life and healthcare utilisation improvements after atrial fibrillation ablation	18
Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease	18
Computed tomographic myocardial mass compared with invasive myocardial perfusion measurement	18
Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation	18
Cumulative burden of clinically significant aortic stenosis in community-dwelling older adults	18
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome	18
Comparison of lifestyle changes and pharmacological treatment on cardiovascular risk factors	18
Improvement of ejection fraction and mortality in ischaemic heart failure	18
Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care	17
Personalised external aortic root support for elective treatment of aortic root dilation in 200 patients	17
Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure	17
Hypereosinophilic syndrome: considerations for the cardiologist	17
Role of echocardiography in screening and evaluation of athletes	17
Familial hypercholesterolaemia: history, diagnosis, screening, management and challenges	17
Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction	17
Pregnancy outcomes in women with aortic coarctation	17
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis	17

Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis	17
Novel bradycardia pacing strategies	17
Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention	17
Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women	17
Acute recurrent pericarditis: from pathophysiology towards new treatment strategy	17
Anti-interleukin 1 agents for the treatment of recurrent pericarditis: a systematic review and meta-analysis	17
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease	16
Temporal trends and sex differences in sudden cardiac death in the Copenhagen City Heart Study	16
Determinants of clinical outcomes of surgery for isolated severe tricuspid regurgitation	16
Considering complexity in the genetic evaluation of dilated cardiomyopathy	16
Outcome and durability of mitral valve annuloplasty in atrial secondary mitral regurgitation	16
Predicting sudden cardiac death in adults with congenital heart disease	16
Cardiovascular magnetic resonance imaging: emerging techniques and applications	16
MINOCA: a heterogenous group of conditions associated with myocardial damage	16
Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation	16
Pathogen influence on epidemiology, diagnostic evaluation and management of infective endocarditis	16
Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis	16
Assessment and management of peripheral arterial disease: what every cardiologist should know	16
D-dimer and the incidence of heart failure and mortality after acute myocardial infarction	16
Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK	16
Effect of meteorological factors and air pollutants on out-of-hospital cardiac arrests: a time series analysis	15
Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke	15
Mortality and morbidity in patients with congenital heart disease hospitalised for viral pneumonia	15
Analysis of sex differences in the clinical presentation, management and prognosis of infective endocarditis in Spain	15
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response	15
Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC)	15
Diagnostic accuracy of handheld cardiac ultrasound device for assessment of left ventricular structure and function: systematic review and meta-analysis	15
Primary prevention of cardiovascular disease in women with a Mediterranean diet: systematic review and meta-analysis	15
Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention	15
Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat	15
Comparison of accelerated diagnostic pathways for acute chest pain risk stratification	15
National Institute for Health and Care Excellence clinical guidelines development principles and processes	15
Association between combat-related traumatic injury and cardiovascular risk	15
Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis	14
Effect of blood pressure lowering drugs and antibiotics on abdominal aortic aneurysm growth: a systematic review and meta-analysis	14
Incident aortic stenosis in 49 449 men and 42 229 women investigated with routine echocardiography	14
The enigmatic immunoglobulin G4-related disease and its varied cardiovascular manifestations	14
Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer	14
Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis	14
Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target	14
N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy	14
Comparative effectiveness of oral anticoagulants in everyday practice	14
Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank	14
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty	14
Preterm birth and cardiac function in adulthood	14
Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation	14
Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure	14
Prognostic impact of cardiac surgery in left-sided infective endocarditis according to risk profile	14
Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation	13
Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease	13
Evaluation of indicators supporting reproducibility and transparency within cardiology literature	13
Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic	13
Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis	13
Contribution of NOTCH1 genetic variants to bicuspid aortic valve and other congenital lesions	13
Relative survival after aortic valve surgery in patients with bicuspid aortic valves	13
Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial	13
Positron emission tomography imaging in cardiovascular disease	13
Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses	13
Diabetes and coronary artery disease: not just a risk factor	13
Association between age at onset of overweight and risk of hypertension across adulthood	13
Spondylodiscitis complicating infective endocarditis	13
Temporal association between invasive procedures and infective endocarditis	13
D-dimer blood concentrations to exclude left atrial thrombus in patients with atrial fibrillation	13
Clinical outcomes of children with rheumatic heart disease	13
Sudden cardiac death in asymptomatic patients with aortic stenosis	13
Chronobiological patterns of acute aortic dissection in central China	13
The new role of diagnostic angiography in coronary physiological assessment	13
Excessive daytime sleepiness: an emerging marker of cardiovascular risk	13
Community pharmacy-based study of adherence to non-vitamin K antagonist oral anticoagulants	13
Trimethylamine oxide: a potential target for heart failure therapy	13
Nuclear cardiology: state of the art	12
Multiple arterial coronary bypass grafting is associated with greater survival in women	12
Mental disorders and cardiovascular disease: what should we be looking out for?	12
Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort	12
Characteristics and outcomes of patients with suspected heart failure referred in line with National Institute for Health and Care Excellence guidance	12
Improving detection and management of familial hypercholesterolaemia in Australian general practice	12
Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy	12
High-sensitivity cardiac troponin and the early rule out of myocardial infarction: time for action	12
Evidence base for the management of women with non-ST elevation acute coronary syndrome	12
Vaping and cardiac disease	12
Flattening the curve in COVID-19 using personalised protective equipment: lessons from air pollution	12
Nickel hypersensitivity and endovascular devices: a systematic review and meta-analysis	12
Opportunities and challenges of implementing computed tomography fractional flow reserve into clinical practice	12
Cost-effectiveness of cardiovascular imaging for stable coronary heart disease	11
Cohort study of intervened functionally univentricular heart in England and Wales (2000–2018)	11
Exercise prescription in individuals with hypertrophic cardiomyopathy: what clinicians need to know	11
Antithrombotic therapy for patients with chronic coronary syndromes	11
Infective endocarditis at a tertiary care hospital in South Korea	11
Role of beta blockers following percutaneous coronary intervention for acute coronary syndrome	11
Cerebrovascular events after transcatheter mitral valve interventions: a systematic review and meta-analysis	11
Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study	11
Evaluation of the causes of sex disparity in heart failure trials	11
Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden	11
Shared decision making in cardiology: a systematic review and meta-analysis	11
Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans	11